Nightingale Health Oyj
NGHLF
$1.75
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.03% | 11.04% | -4.85% | -12.53% | 33.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.03% | 11.04% | -4.85% | -12.53% | 33.24% |
| Cost of Revenue | 114.57% | 108.95% | -16.61% | -23.33% | -21.92% |
| Gross Profit | -8.66% | -11.05% | 1.47% | -6.73% | 58.55% |
| SG&A Expenses | 12.32% | 9.38% | 6.86% | -1.76% | -6.78% |
| Depreciation & Amortization | -14.97% | -17.20% | -2.16% | -10.05% | 9.94% |
| Other Operating Expenses | 17.67% | 14.59% | 59.83% | 46.93% | 14.34% |
| Total Operating Expenses | 6.82% | 4.02% | 11.91% | 2.89% | 2.84% |
| Operating Income | -4.99% | -2.24% | -16.69% | -7.28% | 2.78% |
| Income Before Tax | -17.46% | -14.39% | -21.33% | -11.54% | 4.53% |
| Income Tax Expenses | -209.52% | -204.55% | -15.24% | -22.05% | -85.52% |
| Earnings from Continuing Operations | -17.36% | -14.28% | -21.08% | -11.32% | 4.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.36% | -14.28% | -21.08% | -11.32% | 4.78% |
| EBIT | -4.99% | -2.24% | -16.69% | -7.28% | 2.78% |
| EBITDA | -51.86% | -47.88% | 3.92% | 11.67% | 12.27% |
| EPS Basic | -17.27% | -14.19% | -20.99% | -11.34% | 4.77% |
| Normalized Basic EPS | -17.41% | -14.50% | -21.44% | -11.51% | 4.68% |
| EPS Diluted | -17.27% | -14.19% | -20.99% | -11.34% | 4.77% |
| Normalized Diluted EPS | -17.41% | -14.50% | -21.44% | -11.51% | 4.68% |
| Average Basic Shares Outstanding | 0.03% | 0.03% | 0.02% | 0.02% | 0.00% |
| Average Diluted Shares Outstanding | 0.03% | 0.03% | 0.02% | 0.02% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |